| Sep 2, 2010
The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Wednesday.
| Jun 28, 2011
| 8:23 PM
SAN DIEGO -- A popular cancer drug is under the Federal Drug Administration's microscope this week and the decision could mean life or death for those with breast cancer, according to some patients and doctors.
The drug's maker, Genentech, seeks to...
| Dec 7, 2011
| 4:31 PM
SAN ANTONIO (AP) — Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.
In a large international...
| Jun 5, 2011
| 7:12 PM
For the first time, patients with the deadliest form of skin cancer have two new treatment options that prolong survival, according to new research presented at a cancer conference in Chicago on Sunday.
One drug specifically targets a mutated gene that...
| Jun 6, 2011
| 2:32 PM
MISHAWAKA--- Doctors say a cancer-fighting pill shows promising signs in the fight against melanoma -- the most deadly form of skin cancer.
A local oncologist says drug is not a cure, but it shrank tumors and patients who used the drug lived longer....
| May 8, 2009
The University of California will have two new chancellors this fall, and both of them are women with strong credentials in science and engineering.
The UC Board of Regents on Thursday approved the appointments of Susan Desmond-Hellmann as chancellor...
| May 14, 2009
WILLIAMSBURG – Richard Oropeza Jr. liked to golf and walked up to three miles a day.
Then, in January of 2006, "My left leg just gave out on me."
"It felt like pins and needles," he said. "Twenty minutes later, it went away."
What Oropeza wouldn'...
| Jan 13, 2008
Monday: -- Earnings: Genentech Inc.; M&T Bank Corp.
Tuesday: -- December retail sales -- December producer price index -- November business inventories -- Earnings: Citigroup Inc.; Forest Laboratories Inc.; H.B. Fuller Co.; Intel Corp.; Linear Technology...